Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

NEVRO CORP. (NVRO)

Surgical & Medical Instruments & Apparatus

https://www.nevro.com

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

1800 BRIDGE PARKWAY
REDWOOD CITY, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/06/2014

Market Cap

212,514,240

Shares Outstanding

36,270,000

Weighted SO

36,265,589

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

NUVA --.--%

ITGR --.--%

GKOS --.--%

CNMD --.--%

LUNG --.--%

IRMD --.--%

OFIX --.--%

NPCE --.--%

KIDS --.--%

Beta

0.9090

Last Div

0.0000

Range

4.382-22.64

Chg

-0.0900

Avg Vol

675038

Mkt Cap

212514240

Exch

NYSE

Country

US

Phone

650 251 0005

DCF Diff

37.9564

DCF

-18.9464

Div Yield

0.0000

P/S

0.4987

EV Multiple

-4.9655

P/FV

0.7677

Div Yield %

0.0000

P/E

-2.7186

PEG

-0.1666

Payout

0.0000

Current Ratio

4.7696

Quick Ratio

3.5326

Cash Ratio

0.7328

DSO

63.6230

DIO

313.7914

Op Cycle

377.4144

DPO

57.0815

CCC

320.3329

Gross Margin

0.6558

Op Margin

-0.2203

Pretax Margin

-0.1954

Net Margin

-0.1818

Eff Tax Rate

0.0697

ROA

-0.1284

ROE

-0.2737

ROCE

-0.1872

NI/EBT

0.9303

EBT/EBIT

0.8868

EBIT/Rev

-0.2203

Debt Ratio

0.3626

D/E

0.7977

LT Debt/Cap

0.3970

Total Debt/Cap

0.4437

Int Coverage

-20.6126

CF/Debt

-0.2831

Equity Multi

2.1999

Rec Turnover

5.7369

Pay Turnover

6.3944

Inv Turnover

1.1632

FA Turnover

9.0736

Asset Turnover

0.7062

OCF/Share

-1.6768

FCF/Share

-1.9211

Cash/Share

7.4098

OCF/Sales

-0.1454

FCF/OCF

1.1456

CF Coverage

-0.2831

ST Coverage

-1.6210

CapEx Coverage

-6.8659

Div&CapEx Cov

-6.8659

P/BV

0.7677

P/B

0.7677

P/S

0.4987

P/E

-2.7186

P/FCF

-2.9949

P/OCF

-3.3993

P/CF

-3.3993

PEG

-0.1666

P/S

0.4987

EV Multiple

-4.9655

P/FV

0.7677

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 25, 23:00 $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – NVRO, LGTY, AVTE, PLYA Benzinga Jan 12, 07:00 What Analysts Are Saying About Nevro Stock Zacks Investment Research Dec 26, 11:45 3 Reasons to Retain Nevro (NVRO) in Your Portfolio for Now Benzinga Dec 01, 14:00 Where Nevro Stands With Analysts

Revenue Product Segmentation